164 related articles for article (PubMed ID: 9554825)
1. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
[TBL] [Abstract][Full Text] [Related]
2. Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model.
Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson KJ; Koutalistras N; Wang LS
Aust N Z J Surg; 1996 Aug; 66(8):547-52. PubMed ID: 8712990
[TBL] [Abstract][Full Text] [Related]
3. [Liver support effect of experimental extracorporeal bioartificial liver].
Wang Y; Li M; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983
[TBL] [Abstract][Full Text] [Related]
4. A biodialysis system for liver support tested in a porcine hepatic failure model.
Sheil AG; Sun J; Wang L; Rao N; Mears DC; Wang C; Woodman K; Johnston B; Watson J
Aust N Z J Surg; 2000 Feb; 70(2):127-31. PubMed ID: 10711476
[TBL] [Abstract][Full Text] [Related]
5. Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use.
Kong LB; Chen S; Demetriou AA; Rozga J
Int J Artif Organs; 1996 Jan; 19(1):72-8. PubMed ID: 8641823
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
[TBL] [Abstract][Full Text] [Related]
7. Metabolic aspects of cultured hepatocytes for use in a bioartificial liver support system.
Waring MA; Sun J; Woodman K; Mears DC; Johnston B; Jung SE; Horvat M; Koutalistras N; Watson KJ; Sheil AG
Transplant Proc; 1995 Dec; 27(6):3572-3. PubMed ID: 8540108
[No Abstract] [Full Text] [Related]
8. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
[TBL] [Abstract][Full Text] [Related]
9. Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver?
Flendrig LM; Maas MA; Daalhuisen J; Ladiges NC; La Soe JW; Te Velde AA; Chamuleau RA
Int J Artif Organs; 1998 Sep; 21(9):542-7. PubMed ID: 9828060
[TBL] [Abstract][Full Text] [Related]
10. In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation.
Morsiani E; Pazzi P; Moscioni AD; Rozga J; Azzena G; Demetriou AA
J Surg Res; 1998 Sep; 79(1):54-60. PubMed ID: 9735240
[TBL] [Abstract][Full Text] [Related]
11. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.
Desille M; Mahler S; Seguin P; Mallédant Y; Frémond B; Sébille V; Bouix A; Desjardins JF; Joly A; Desbois J; Lebreton Y; Campion JP; Clément B
Crit Care Med; 2002 Mar; 30(3):658-63. PubMed ID: 11990930
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy.
Kanai H; Marushima H; Kimura N; Iwaki T; Saito M; Maehashi H; Shimizu K; Muto M; Masaki T; Ohkawa K; Yokoyama K; Nakayama M; Harada T; Hano H; Hataba Y; Fukuda T; Nakamura M; Totsuka N; Ishikawa S; Unemura Y; Ishii Y; Yanaga K; Matsuura T
Artif Organs; 2007 Feb; 31(2):148-51. PubMed ID: 17298404
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver.
Sielaff TD; Nyberg SL; Rollins MD; Hu MY; Amiot B; Lee A; Wu FJ; Hu WS; Cerra FB
Cell Biol Toxicol; 1997 Jul; 13(4-5):357-64. PubMed ID: 9298256
[TBL] [Abstract][Full Text] [Related]
14. Improvement of C3A cell metabolism for usage in bioartificial liver support systems.
Filippi C; Keatch SA; Rangar D; Nelson LJ; Hayes PC; Plevris JN
J Hepatol; 2004 Oct; 41(4):599-605. PubMed ID: 15464240
[TBL] [Abstract][Full Text] [Related]
15. Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver.
Tréhout D; Desille M; Doan BT; Mahler S; Frémond B; Mallédant Y; Campion JP; Desbois J; Beloeil JC; de Certaines J; Clément B
NMR Biomed; 2002 Oct; 15(6):393-403. PubMed ID: 12357553
[TBL] [Abstract][Full Text] [Related]
16. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
[TBL] [Abstract][Full Text] [Related]
17. [A step towards a bioartificial liver: temporary extracorporeal replacement using isolated hepatocytes].
Clément B; Frémond B; Joly A; Desjardins JF; Campion JP; Guillouzo A; Bourel M
Bull Acad Natl Med; 1996 Oct; 180(7):1753-63; discussion 1764-7. PubMed ID: 9102156
[TBL] [Abstract][Full Text] [Related]
18. Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver.
Hochleitner B; Hengster P; Bucher H; Ladurner R; Schneeberger S; Krismer A; Kleinsasser A; Barnas U; Klima G; Margreiter R
Artif Organs; 2006 Dec; 30(12):906-14. PubMed ID: 17181831
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model.
Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244
[TBL] [Abstract][Full Text] [Related]
20. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
